ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,337Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 917

$441K Total Retail Price of All Prescriptions

Rank: 162 out of 917

496 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
OMEPRAZOLE 349 297 1 4
LEVOTHYROXINE SODIUM 324 278 2 3
SIMVASTATIN 313 272 3 2
HYDROCODONE-ACETAMINOPHEN 308 234 S3 4 6
LISINOPRIL 266 228 5 1
AMLODIPINE BESYLATE 154 153 6 5
FUROSEMIDE 152 139 7 7
ATORVASTATIN CALCIUM 119 119 8 14
METOPROLOL SUCCINATE 119 116 8 18
DONEPEZIL HCL 107 107 10 32
TRAZODONE HCL 98 80 11 22
POTASSIUM CHLORIDE 97 82 12 16
NAMENDA 94 94 13 43
GABAPENTIN 91 78 14 17
SERTRALINE HCL 83 68 15 24
METFORMIN HCL 82 69 16 8
SPIRONOLACTONE 81 49 17 55
CITALOPRAM HBR 79 74 18 15
FLUOXETINE HCL 79 66 18 38
ALENDRONATE SODIUM 77 75 20 23
CARVEDILOL 75 75 21 33
CLOPIDOGREL 71 68 22 50
ZOLPIDEM TARTRATE 71 63 22 21
POLYETHYLENE GLYCOL 3350 70 65 24 66
METOPROLOL TARTRATE 68 64 25 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 57 26 42
LOSARTAN POTASSIUM 65 65 27 13
LOSARTAN-HYDROCHLOROTHIAZIDE 63 61 28 62
MIRTAZAPINE 57 57 29 39
PREDNISONE 56 43 30 34
CRESTOR 55 32 31 30
PANTOPRAZOLE SODIUM 54 41 32 44
METHADONE HCL 54 21 S2 32 59
PRAVASTATIN SODIUM 53 52 34 20
OXYCODONE HCL 53 30 S2 34 27
NEXIUM 51 31 36 60
VERAPAMIL ER 51 51 36 145
ACETAMINOPHEN-CODEINE 51 47 S3 36 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.